AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8701411
Drug: Cyclic transdermal
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic transdermal E2 (50 micrograms/day for 21 days) plus medroxyprogesterone acetate (MPA) (10 mg/day from days 10 to 21)
Trial: 8701411
Drug: Continuous transdermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous transdermal E2 (50 micrograms/day for 28 days) plus MPA (10 mg/day from days 14 to 25)
Trial: 1906532
Drug: Gallium nitrate
RxNorm normalized name: Gallium Nitrate
DrugBank: Gallium citrate (DB17893)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gallium nitrate (200 mg/m2/d by continuous IV infusion for 5 days)
Trial: 1906532
Drug: Etidronate (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate (7.5 mg/kg as a 4-hour IV infusion for 5 days)
Trial: 1906532
Drug: Etidronate (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate (7.5 mg/kg)
Trial: 2988108
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no fiber preparation)
Trial: 18810296
Drug: HI PROT
RxNorm normalized name: NUTRITION SUPL BOOST HI PROTEIN/VAN LIQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HI PROT (30% of total energy intake; 1.2-1.5 g/kg/d)
Trial: 18810296
Drug: LO PROT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LO PROT (15% of total energy intake; 0.5-0.7 g/kg/d)
Trial: 9725505
Drug: beta-D-galactosidase pellets
RxNorm normalized name: BETA-D-GALACTOSIDASE
DrugBank: Tilactase (DB13761)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-D-galactosidase pellets (100 u/ml)
Trial: 2557219
Drug: Conventional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heparin (high-dose)
Trial: 2557219
Drug: Conventional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heparin (low-dose)
Trial: 2557219
Drug: Any form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any form of heparin therapy
Trial: 239807
Drug: Pentazocine 30
RxNorm normalized name: pentazocine 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine 30 mg intramuscularly
Trial: 1217684
Drug: Doxapram 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram 60 mg intramuscularly
Trial: 1217684
Drug: Doxapram 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram 60 mg intramuscularly with Pentazocine 30 mg
Trial: 24323569
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all three triggers (alcohol consumption, presence of others smoking, negative affect)
Trial: 25198082
Drug: Collagenase ointment
RxNorm normalized name: collagenase Topical Ointment
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collagenase ointment (CO)
Trial: 17710398
Drug: Pegfilgrastim (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegfilgrastim (6 mg single dose on day +5)
Trial: 7578896
Drug: gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil (600 mg b.i.d.)
Trial: 31897661
Drug: Oregovomab combined
RxNorm normalized name: Oregovomab
DrugBank: Oregovomab (DB04964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oregovomab combined with standard-of-care (SOC) therapy
Trial: 31897661
Drug: Standard-of-care (SOC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care (SOC) therapy alone
Trial: 25567069
Drug: Brazil nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazil nuts (288.75 µg/day) for 6 months
Trial: 20813339
Drug: aMCI patients
RxNorm normalized name: Amcinonide
DrugBank: Amcinonide (DB00288)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: aMCI patients fulfilling biomarker criteria (CSF Aβ1‐42 ≤192 mg/mL or total‐tau/Aβ1‐42 >0.39)
Trial: 12145593
Drug: Erythromycin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (3 mg/kg intravenously over 30 minutes)
Trial: 10673879
Drug: Cyclizine 50
RxNorm normalized name: cyclizine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclizine 50 mg i.v.
Trial: 7562882
Drug: Lisinopril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (20 mg/day before breakfast) for 4 and 8 weeks
Trial: 1834827
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of teicoplanin (6 mg/kg)
Trial: 1834827
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of teicoplanin (6 mg/kg)
Trial: 1834827
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered by the other route)
Trial: 22371069
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine administered at 6 and 12 months (Group 1)
Trial: 22371069
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine administered at 12 and 18 months (Group 2)
Trial: 22371069
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine administered at 15 and 21 months (Group 3)
Trial: 26190562
Drug: Allopurinol 300
RxNorm normalized name: allopurinol 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 300 mg
Trial: 9360756
Drug: Loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (10 mg OD)
Trial: 3715789
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin formulations (300-650 mg)
Trial: 29329996
Drug: Antiflatulent medication
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiflatulent medication
Trial: 24673048
Drug: Warm acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm acupuncture therapy
Trial: 24032192
Drug: Electroacupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture therapy
Trial: 22153972
Drug: Pramipexole (4.25±0.38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (4.25±0.38 mg/day)
Trial: 20514506
Drug: Pelvic autonomic
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic autonomic nerve preservation during rectal cancer surgery
Trial: 17680204
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received continuous infusion of fentanyl 30 microg x ml(‐1) and 2 mg/ml bupivacaine at a rate of 0.7 ml x h(‐1) for 72 h postoperatively
Trial: 11889009
Drug: NTG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTG group (48 hours of continuous NTG infusion)
Trial: 9606617
Drug: Bicalutamide 50
RxNorm normalized name: bicalutamide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 50 mg once daily
Trial: 2038931
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine (3 mg/kg)
Trial: 27544517
Drug: Treatment-as-usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (TAU) Control
Trial: 21462240
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 60 mg XR once daily
Trial: 9771983
Drug: TRUE Test
RxNorm normalized name: SunMark True Test Strips
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRUE Test patch test (0.20 mg/cm2 for 48 h)
Trial: 1004355
Drug: Molsidomine 2
RxNorm normalized name: molsidomine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine 2 mg (sublingual or enteral)
Trial: 1004355
Drug: Isosorbiddinitrate 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbiddinitrate 20 mg (sublingual)
Trial: 23701973
Drug: Complex Ayurvedic
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex Ayurvedic treatment including tailored combinations of manual treatments, massages, dietary and lifestyle advice, nutritional supplements, yoga posture advice, and knee massage.
Trial: 23701973
Drug: Conventional standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional standard care including self-care advice, pain medication, weight-loss advice (if overweight), and physiotherapy following current international guidelines.
Trial: 23701973
Drug: Complex Ayurvedic
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex Ayurvedic treatment
Trial: 22028817
Drug: Water Guard
RxNorm normalized name: HYPOCHLOROUS ACID 0.008 mg in 100 mL CUTANEOUS SPRAY [Water Guard Slightly Acidic Electrolyzed Hypochlorous Acid Water Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water Guard (sodium hypochlorite solution)
Trial: 22028817
Drug: Sodium dichloroisocyanurate
RxNorm normalized name: Sodium dichloroisocyanurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium dichloroisocyanurate tablets (Aquatabs)
Trial: 19019624
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (ASA 100 mg/d)
Trial: 19019624
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus clopidogrel (ASA 100 mg/d + C 75 mg/d)
Trial: 25219200
Drug: Rush immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rush immunotherapy (RIT)
Trial: 3310722
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release morphine tablets (twice daily)
Trial: 3310722
Drug: Aqueous morphine
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous morphine sulphate (4-hourly)
Trial: 24074707
Drug: Entecavir (ETV)
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir (ETV) continued therapy
Trial: 20522795
Drug: valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan (160 mg)
Trial: 15478553
Drug: Artificial pneumothorax
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial pneumothorax (AP) during chemotherapy with reserve drugs
Trial: 1343270
Drug: Combination therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy, ACE inhibitors, methyldopa
Trial: 1679517
Drug: beta-blockers
RxNorm normalized name: BETA-BLOCKERS,TOPICAL OPHTHALMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blockers
Trial: 3909336
Drug: Single 1-g
RxNorm normalized name: bacitracin
DrugBank: Bacitracin (DB00626)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single 1-g intramuscular dose of aztreonam for acute uncomplicated cystitis
Trial: 3909336
Drug: Multiple parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple parenteral doses of aztreonam (usually a five-day course of 1 g two or three times daily)
Trial: 3909336
Drug: Multiple-dose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose therapy of aztreonam
Trial: 3909336
Drug: Multiple-dose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose therapy of aztreonam in patients with multiply drug-resistant bacteria
Trial: 29553453
Drug: Specific health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific health provider, receiving all medications from UNRWA, not turned away from clinic
Trial: 29553453
Drug: Sex, age,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex, age, presence of disability, presence of complications, control status, kind of non-communicable disease, type of treatment provided, duration of non-communicable disease
Trial: 24508026
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (50,000 IU weekly for 6 months)
Trial: 15233669
Drug: interferon alpha‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: interferon alpha‐2a 3 MIU thrice weekly
Trial: 9572829
Drug: Iron supplement
RxNorm normalized name: Iron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplement (135 mg/day)
Trial: 8083793
Drug: Comprehensive oral
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive oral hygiene training program (3.5 hours per child)
Trial: 8083793
Drug: Less comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less comprehensive oral hygiene training program (1.5 hours per child)
Trial: 2479963
Drug: Immediate combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate combination chemotherapy and radiotherapy
Trial: 2479963
Drug: Selective treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective treatment (chemotherapy and/or radiotherapy as needed)
Trial: 781336
Drug: Kaolin‐pectin suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kaolin‐pectin suspension concentrate (Kao‐Con)
Trial: 781336
Drug: Kaolin suspension
RxNorm normalized name: Kaolin
DrugBank: Kaolin (DB01575)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kaolin suspension
Trial: 781336
Drug: Pectin suspension
RxNorm normalized name: KAOLIN 208.1 g in 1 L / PECTIN 8.8 g in 1 L ORAL SUSPENSION [Kaolin pectin Suspension]
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pectin suspension
Trial: 23425732
Drug: TEG‐guided prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEG‐guided prophylaxis with escalating low‐molecular weight heparin (LMWH) up to 5,000 IU twice daily with the addition of aspirin
Trial: 23425732
Drug: 5,000 IU
RxNorm normalized name: bleopmycin 15,000 IU Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 IU of LMWH daily (control)
Trial: 22087615
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement containing standardized lemon verbena extract (14% verbascoside, w/w) and fish oil omega-3 fatty acid
Trial: 15017517
Drug: Sucralfate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (2 g, 10 mL suspension, twice a day for 6 weeks)
Trial: 10834412
Drug: Nighttime-only insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nighttime-only insulin pump therapy
Trial: 9076405
Drug: Plain ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain ascorbic acid (250 mg BID)
Trial: 9076405
Drug: Slow release
RxNorm normalized name: Slow Release Iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow release ascorbic acid (250 mg BID)
Trial: 23702047
Drug: Hygiene promotion
RxNorm normalized name: PROMOTE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hygiene promotion and water treatment (HP&WT) and sanitation improvements in 'water-available' schools
Trial: 23702047
Drug: Hygiene promotion
RxNorm normalized name: PROMOTE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hygiene promotion and water treatment (HP&WT) in 'water-available' schools
Trial: 20050880
Drug: Alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-lipoic acid (ALA) 600 mg intravenous treatment for 21 days
Trial: 15045685
Drug: Glipizide GITS
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide GITS (5 mg/d)
Trial: 9051543
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (bolus 0.015 mg/kg followed by an infusion 0.003 mg/kg/hr)
Trial: 9051543
Drug: Epidural oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural oxycodone (bolus 0.15 mg/kg followed by an infusion 0.03 mg/kg/hr)
Trial: 9051543
Drug: Intravenous oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous oxycodone (same dose as in the epidural group)
Trial: 8112441
Drug: Bambuterol, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bambuterol, 10 mg once daily
Trial: 8112441
Drug: Terbutaline, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline, 5 mg controlled release twice daily
Trial: 2877127
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg indenolol once a day for 14 days
Trial: 2877127
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg indenolol once a day for 14 days
Trial: 27239902
Drug: Oral biographical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral biographical disclosure
Trial: 27586686
Drug: Daily diary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily diary
Trial: 15986443
Drug: Former oral
RxNorm normalized name: Triple Wormer Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Former oral contraceptive use
Trial: 15986443
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive use, Norplant use, history of pregnancy, age at first pregnancy, lifetime numbers of pregnancies and live births
Trial: 1513608
Drug: Loracarbef (15‐mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loracarbef (15‐mg/kg/day oral suspension or 200‐mg capsule taken twice daily for 10 days)
Trial: 1513608
Drug: Penicillin VK
RxNorm normalized name: PENICILLIN VK 250MG TAB
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin VK (20‐mg/kg/day oral suspension or 250‐mg capsule taken four times daily for 10 days)
Trial: 6337473
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin ethylsuccinate (40 mg/kg/day in divided doses) for five days
Trial: 29856768
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (supervised training sessions three times weekly and home exercise once weekly)
Trial: 26813468
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g Hawaiian spirulina daily for three months
Trial: 17502530
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus 400 IU of cholecalciferol (vitamin D) daily
Trial: 12804729
Drug: Niacin ER
RxNorm normalized name: Niacin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin ER 1,000 mg/day
Trial: 12804729
Drug: Niacin ER
RxNorm normalized name: Niacin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin ER 2,000 mg/day
Trial: 1354938
Drug: Ibopamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine (100 mg, 3 times daily)
Trial: 1354938
Drug: Ibopamine (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine (acute administration)
Trial: 1354938
Drug: Ibopamine (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine (chronic administration)
Trial: 1354938
Drug: Ibopamine (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine (acute and chronic administration)
Trial: 6423720
Drug: Ethanol infusion
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol infusion (0.4 g/kg)
Trial: 6423720
Drug: Ethanol infusion
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol infusion (0.8 g/kg)
Trial: 30969797
Drug: Denosumab (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (120 mg)
Trial: 20141705
Drug: TAU augmented
RxNorm normalized name: Interferon tau
DrugBank: Interferon tau (DB16972)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAU augmented with brief group cognitive therapy (CT)
Trial: 8688398
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose ritodrine infusion
Trial: 8688398
Drug: Conventional schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional schedule of increasing doses of ritodrine
Trial: 373072
Drug: Atropine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.5 mg)
Trial: 30761568
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal therapy (PT)
Trial: 27390130
Drug: IV→150 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV→150 mg secukinumab
Trial: 27390130
Drug: IV→75 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV→75 mg secukinumab
Trial: 18605891
Drug: Conventional surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional surgical therapy
Trial: 10505301
Drug: Cerivastatin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin treatment
Trial: 2012456
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of aspirin with 64 mg of caffeine
Trial: 2012456
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of aspirin